Last reviewed · How we verify

NCT05270356: MINDS

MINDS Imaging Ancillary Study

Completed Last updated 31 October 2025
What this trial tests

trial testing MRI in Adult Congenital Heart Disease in 195 participants. Completed in 31 May 2025.

Timeline
27 May 2021
Primary endpoint
31 May 2025
31 May 2025

Quick facts

Lead sponsorUniversity of Pittsburgh
StatusCompleted
Study typeOBSERVATIONAL
Enrollment195
Start date27 May 2021
Primary completion31 May 2025
Estimated completion31 May 2025
Sites13 locations across Canada, United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Pittsburgh

Who can join

Adults 18 to 30, any sex, with Adult Congenital Heart Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is an ancillary study to the NHLBI-funded Pediatric Heart Network (PHN) "Multi-Institutional Neurocognitive Discovery Study" (MINDS) in Adult Congenital Heart Disease (ACHD). The MINDS-ACHD" study will recruit 500 complex CHD patients between18-30 years old. The investigators propose to quantitate multi-modal neuroimaging biomarkers (brain injury, structure and physiology) which are not only important components of brain and cognitive reserve but can be predictive of neurocognitive decline and early onset of dementia in the aging non-CHD population.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Design and Harmonization Approach for the Multi-Institutional Neurocognitive Discovery Study (MINDS) of Adult Congenital Heart Disease (ACHD) Neuroimaging Ancillary Study: A Technical Note.
    Panigrahy A, Schmithorst V, Ceschin R, Lee V, et al · · 2023 · cited 2× · PMID 37754810 · DOI 10.3390/jcdd10090381

Verify or expand the search:

Other trials of MRI

Trials testing the same drug.

Other recruiting trials for Adult Congenital Heart Disease

Currently open trials in the same condition.

Other University of Pittsburgh trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05270356.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing